HOME >> BIOLOGY >> NEWS
Tweaking the treatment for restless legs

"The best drugs for restless leg syndrome sometimes can only work for a time. Then they boomerang."

Last Super Bowl, a TV commercial lauded the power of Requip (ropinirole), the first drug approved to treat restless leg syndrome, a condition whose signature feature is creepy-crawly leg sensations that interfere with sleep and rest in nearly 1 of every 10 adults.

But if taken too long, the drug can actually backfire, causing symptoms to worsen, say doctors who specialize in treating the condition. They say that treatment that rotates through different types of medications may be needed for many patients.

"Its impossible to tell the whole story in a TV spot just a few seconds long," said Irene Richard, M.D, a movement disorder neurologist at the University of Rochester Medical Center. "When patients come in asking about the treatment, doctors need to know that this is usually not a simple, single-pill solution, despite what theyve seen on TV."

In an article published in the December issue of the Journal of General Internal Medicine, Richard and fellow neurologist Roger Kurlan, M.D., warn primary care physicians that they cannot expect long-term success by simply prescribing ropinirole or a similar medication in its class, which works by activating dopamine receptors in the brain. Instead, the team experts at treating movement disorders like Parkinsons disease, Tourettes syndrome and restless leg syndrome recommends that physicians may need to rotate some patients through these drugs along with different types of medications.

"The truth is, some of the most common, most effective drugs, including ropinirole and pramipexole, which was recently approved to treat restless leg syndrome, may only work effectively for each person for a limited time," Kurlan said. "After that, this class of drugs albeit the most-popular, effective, and the only one approved by the Food and Drug Administration for restless leg syndrome has a regre
'"/>

Contact: Becky Jones
rebecca_jones@urmc.rochester.edu
585-275-8490
University of Rochester Medical Center
20-Dec-2006


Page: 1 2 3

Related biology news :

1. Tweaking Taxol points way to a greener, more productive future
2. New system of wastewater treatment could reduce the size of treatment plants by half
3. UCF research links proteins, stem cells and potential Alzheimers treatment
4. Geisinger scientist seeks cure for Lou Gehrigs disease, creating device to find treatment
5. System to analyze beating heart stem cells could lead to heart attack treatments
6. Gene expression pattern could lead to improved treatment of pediatric septic shock
7. Molecular detectors may refine cancer treatment
8. First genome-wide study of infectious disease opens new avenues for HIV treatment, vaccines
9. A new method of adult stem cell growth efficacious in treatment of disorders of the cornea
10. Scientists take next step in understanding potential target for ovarian cancer treatment
11. New treatment model for HIV

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/1/2019)... ... May 31, 2019 , ... ... & Rosati recently invested in BioFactura’s $6M Series B Financing Round. , ... value-added institutional investors who bring significant financial and business resources to bear as ...
(Date:5/31/2019)... ... May 31, 2019 , ... The OilComm Conference & ... announced today that Ben Reiter, Senior Writer at Sports Illustrated and Author of ... , Reiter predicted the Houston Astros would win the MLB championship in 2014 ...
(Date:5/23/2019)... (PRWEB) , ... May 23, 2019 , ... ... Virtual Agents for sales and service organizations, today announced its inclusion in ... Inference Solutions as the intelligent virtual agent (IVA) market share leader, based on ...
Breaking Biology News(10 mins):
(Date:5/22/2019)... ... May 22, 2019 , ... Artemis (formerly Agrilyst), the ... Series A funding round co-led by Astanor Ventures and Talis Capital ... and iSelect Fund . The company has raised $11.75m to date and ...
(Date:5/15/2019)... ... , ... Milton Hershey School® has named William Charles Ballough Harding ’78 the ... where he is changing lives by creating solutions to global healthcare challenges through the ... of our founders – Milton and Catherine Hershey – who always hoped for Milton ...
(Date:5/14/2019)... N.J. (PRWEB) , ... May 13, 2019 , ... ... custom built, helium-based leak testing instruments for the Pharmaceutical, Biotechnology, Medical Device and ... Heliumleak.com company website. The redesigned website aims to improve LDA’s ability to communicate ...
(Date:5/8/2019)... Calif. (PRWEB) , ... May 07, 2019 , ... Standing at 16.2 hands, Atlas is ... too, participating in a drill team and barrel racing, among other activities. When loping ... ligament. He went from being a busy horse to only being able to walk. ...
Breaking Biology Technology:
Cached News: